The aim of the study was to investigate the results of bladder irrigation with Water for Injection (WFI)after transurethral resection of bladder tumours for comparison with those for adjuvant use of BCG. A total of239 patients (158 with single tumours, group A, and 81 with multiple tumours, group B) received continuousintravesical postoperative irrigation with WFI. Some 128 patients received intravesical irrigation with WFI,followed by weekly instillations of BCG (group C). Recurrence-free rate (RFR) and recurrence-free intervals(RFI) were recorded. RFR for those patients who received only intravesical irrigation with WFI (groups A andB) was 75.8%, 66.2% and 63.2% at the 1st, 2nd and 3rd year of follow up, respectively. Corresponding ratesfor group C were 61.7%, 55.4% and 49%. Median RFI in group B were 18, 11, 15, 15 and 12 months for Ta, T1,grade 1, grade 2 and grade 3 tumours, respectively. In group C corresponding intervals were 20, 33, 8, 20 and 42months. BCG improved RFR only in T1 (p=0.014) and grade 3 tumours (p=0.007). In conclusion, postoperativebladder irrigation with WFI could increase RFR during the first and second year of follow up.